Investigation of prognostic markers in endemic Burkitt lymphoma

Peixun Zhou; Alexander Newman; Susan Van Noorden; Kondwani Banda; George Chagaluka; Irvin  Lampert; Amy Erhorn; Chris Bacon; Simon  Bailey; Elizabeth  Molyneux; Vikki Rand

Investigation of prognostic markers in endemic Burkitt lymphoma

Peixun Zhou
, Alexander Newman
, Susan Van Noorden
, Kondwani Banda
, George Chagaluka
, Irvin Lampert
, Amy Erhorn
, Chris Bacon
, Simon Bailey
, Elizabeth Molyneux
, Vikki Rand

Research output: Contribution to journal › Meeting Abstract › peer-review

Abstract

Unlike many other childhood cancers, genomic abnor-
malities are not used in the clinical management of paediatric Bur-
kitt lymphoma (BL) and few prognostic biomarkers have been
identiﬁed. In sporadic BL gain of chromosome 7 and deletion of 13q
are the only abnormalities that have been associated with an adverse
prognosis in the context of a clinical trial. Gains of 13q have also
been reported, including gain of the miR17HG locus, but the prog-
nostic value in endemic BL is unknown

Original language	English
Pages (from-to)	2-2
Journal	British Journal of Haematology
Volume	171
Issue number	Suppl 1
Publication status	Published - 4 Oct 2015
Event	Fifth International Symposium on Childhood Adolescent and Young Adult Non-Hodgkin Lymphoma - Varase, Italy Duration: 22 Oct 2015 → 24 Oct 2015 https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.13753

Access to Document

https://onlinelibrary.wiley.com/doi/10.1111/bjh.13753

Cite this

@article{babb8a51baa8438ab196af7c17f11416,

title = "Investigation of prognostic markers in endemic Burkitt lymphoma",

abstract = "Unlike many other childhood cancers, genomic abnor- malities are not used in the clinical management of paediatric Bur- kitt lymphoma (BL) and few prognostic biomarkers have been identiﬁed. In sporadic BL gain of chromosome 7 and deletion of 13q are the only abnormalities that have been associated with an adverse prognosis in the context of a clinical trial. Gains of 13q have also been reported, including gain of the miR17HG locus, but the prog- nostic value in endemic BL is unknown",

author = "Peixun Zhou and Alexander Newman and \{Van Noorden\}, Susan and Kondwani Banda and George Chagaluka and Irvin Lampert and Amy Erhorn and Chris Bacon and Simon Bailey and Elizabeth Molyneux and Vikki Rand",

year = "2015",

month = oct,

day = "4",

language = "English",

volume = "171",

pages = "2--2",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "John Wiley and Sons Inc.",

number = "Suppl 1",

note = "Fifth International Symposium on Childhood Adolescent and Young Adult Non-Hodgkin Lymphoma ; Conference date: 22-10-2015 Through 24-10-2015",

url = "https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.13753",

}

TY - JOUR

T1 - Investigation of prognostic markers in endemic Burkitt lymphoma

AU - Zhou, Peixun

AU - Newman, Alexander

AU - Van Noorden, Susan

AU - Banda, Kondwani

AU - Chagaluka, George

AU - Lampert, Irvin

AU - Erhorn, Amy

AU - Bacon, Chris

AU - Bailey, Simon

AU - Molyneux, Elizabeth

AU - Rand, Vikki

PY - 2015/10/4

Y1 - 2015/10/4

N2 - Unlike many other childhood cancers, genomic abnor- malities are not used in the clinical management of paediatric Bur- kitt lymphoma (BL) and few prognostic biomarkers have been identiﬁed. In sporadic BL gain of chromosome 7 and deletion of 13q are the only abnormalities that have been associated with an adverse prognosis in the context of a clinical trial. Gains of 13q have also been reported, including gain of the miR17HG locus, but the prog- nostic value in endemic BL is unknown

AB - Unlike many other childhood cancers, genomic abnor- malities are not used in the clinical management of paediatric Bur- kitt lymphoma (BL) and few prognostic biomarkers have been identiﬁed. In sporadic BL gain of chromosome 7 and deletion of 13q are the only abnormalities that have been associated with an adverse prognosis in the context of a clinical trial. Gains of 13q have also been reported, including gain of the miR17HG locus, but the prog- nostic value in endemic BL is unknown

M3 - Meeting Abstract

SN - 0007-1048

VL - 171

SP - 2

EP - 2

JO - British Journal of Haematology

JF - British Journal of Haematology

IS - Suppl 1

T2 - Fifth International Symposium on Childhood Adolescent and Young Adult Non-Hodgkin Lymphoma

Y2 - 22 October 2015 through 24 October 2015

ER -

Investigation of prognostic markers in endemic Burkitt lymphoma

Abstract

Access to Document

Fingerprint

Cite this